Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sri HariKrishna Vellanki

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Lab on a Chip|March 15, 2012
Determination of single cell surface protein expression using a tagless microfluidic methodRajan Kumar, Sri HariKrishna Vellanki, Robin Smith, et al.
World Journal of Biological Chemistry|March 17, 2016
Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalkYvonne E Smith, Sri HariKrishna Vellanki, Ann M Hopkins
Cancer Letters|October 13, 2018
Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growthSri HariKrishna Vellanki, Rodrigo G B Cruz, Hanne Jahns, et al.
Anticancer Research|March 8, 2019
Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer ModelsSri Harikrishna Vellanki, Rodrigo G B Cruz, Cathy E Richards, et al.
Molecular Cancer Therapeutics|August 24, 2011
NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosisRebecca Berger, Claudia Jennewein, Viola Marschall, et al.
Cancers|March 6, 2021
Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1Rodrigo G B Cruz, Stephen F Madden, Cathy E Richards, et al.
Breast Cancer Research : BCR|November 22, 2018
Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settingsAstrid O Leech, Sri HariKrishna Vellanki, Emily J Rutherford, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Lab on a Chip|March 15, 2012
Determination of single cell surface protein expression using a tagless microfluidic methodRajan Kumar, Sri HariKrishna Vellanki, Robin Smith, et al.
World Journal of Biological Chemistry|March 17, 2016
Dynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalkYvonne E Smith, Sri HariKrishna Vellanki, Ann M Hopkins
Cancer Letters|October 13, 2018
Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growthSri HariKrishna Vellanki, Rodrigo G B Cruz, Hanne Jahns, et al.
Anticancer Research|March 8, 2019
Antibiotic Tetrocarcin-A Down-regulates JAM-A, IAPs and Induces Apoptosis in Triple-negative Breast Cancer ModelsSri Harikrishna Vellanki, Rodrigo G B Cruz, Cathy E Richards, et al.
Molecular Cancer Therapeutics|August 24, 2011
NF-κB is required for Smac mimetic-mediated sensitization of glioblastoma cells for γ-irradiation-induced apoptosisRebecca Berger, Claudia Jennewein, Viola Marschall, et al.
Cancers|March 6, 2021
Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1Rodrigo G B Cruz, Stephen F Madden, Cathy E Richards, et al.
Breast Cancer Research : BCR|November 22, 2018
Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settingsAstrid O Leech, Sri HariKrishna Vellanki, Emily J Rutherford, et al.
Pageof 1